Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8 <sup>+</sup> HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington

Publication | Closed Access

DOI

Citations

References

1992

Year

S. Riddell, P D Greenberg, Robert W. Overell, T. P. Loughran, M. Jean Gilbert, Stephen D. Lupton, Jan M. Agosti, S. Scheeler, R. W. Coombs, Lawrence Corey

Human Gene Therapy